Connect your AI

Schrodinger SDGR Change in Other Assets

Change in Other Assets at other companies

Recursion Pharmaceuticals, Inc.RXRX

-$14.75M-205%

Absci CorporationABSI

$0+100%

AbCellera Biologics Inc.ABCL

$1.74M+124%

Certara, Inc.CERT

$2.65M+247%

Septerna, Inc.SEPN

$294K-39.8%

Stoke Therapeutics, Inc.STOK

$3.59M+192%

Other financials

Income statement

Revenue$58.6M-1.6%

Gross profit$29.5M-5.1%

Operating income-$48.8M+4.1%

Net income-$60.0M-0.4%

EPS (diluted)-$0.81+1.2%

Balance sheet

Cash & equivalents$267.7M-20.7%

Total debt$107.0M-7.9%

Total equity$313.5M-16.1%

Total assets$634.2M-14.6%

Cash flow

Operating cash flow-$14.8M-110%

CapEx$2.5M+321%

Free cash flow-$17.3M-112%

Valuation

Market cap$1.15B-23.7%

Enterprise value$984.71M-23.1%

P/S4.5×-2.0×

Profitability

Gross margin55.3%-7.3pp

Operating margin-64.7%-12.0pp

Net margin-68.5%—

FCF margin9.6%+5.1pp

Returns & leverage

Return on equity-45.7%—

Debt / equity0.3×0.0×

Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Schrodinger's change in other assets?: Schrodinger (SDGR) reported change in other assets of -$4.49M in Q1 2026.
How has Schrodinger's change in other assets changed year-over-year?: Schrodinger's change in other assets decreased by 669.3% year-over-year, from $788K to -$4.49M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.